Search articles, concepts, and chapters
45 articles in GJC
Benoit Olivier, Jumelle Clotilde, Meunier Esmeralda, Sourdille Philippe, Baudouin Christophe, Labbe Antoine
This study developed a model to estimate unmedicated IOP after glaucoma medication washout. It accurately predicted IOP changes, offering a tool to assess treatment effects when washout isn't feasible.
Baudouin Christophe, Myers Jonathan S, Van Tassel Sarah H, Goyal Nina A, Martinez-de-la-Casa Jose, Ng Alvin et al.
A review of glaucoma patients on prostaglandin analogues found low adherence (44% at year 1) and persistence, decreasing over time. This highlights the value of procedural glaucoma treatments.
Baudouin Christophe, Stalmans Ingeborg, Bourne Rupert, Larrosa Jose Manuel, Schmickler Stefanie, Seleznev Aleksey et al.
Preservative-free latanoprost effectively lowered IOP similar to preserved latanoprost in glaucoma/OHT, while also improving ocular surface disease signs, offering a better option for patient comfort.
Bastelica Paul, Labbé Antoine, Hamard Pascale, Rossant Florence, Urien Hélène, Sublime Jérémie et al.
This study found high-tension glaucoma causes more tortuous lamina cribrosa pores than healthy eyes, while normal-tension glaucoma has shorter pores, both correlating with disease severity.
Kahook Malik Y, Rapuano Christopher J, Messmer Elisabeth M, Radcliffe Nathan M, Galor Anat, Baudouin Christophe
Preservatives in glaucoma drops, especially BAK, cause ocular surface disease. Reducing/eliminating BAK via preservative-free options or non-pharmacological treatments improves patient quality of life and surgical outcomes.
Messmer Elisabeth M, Baudouin Christophe, Benitez-Del-Castillo José-Manuel, Iester Michele, Anton Alfonso, Thygesen John et al.
Experts developed 24 consensus recommendations for managing ocular surface inflammation in glaucoma patients. Key findings emphasize investigating OSI in all glaucoma patients, minimizing preserved drops, and using a subtractive treatment approach to improve ocular health.
Louanchi Yanis, Brasnu Emmanuelle, Hamard Pascale, Aragno Vittoria, Baudouin Christophe, Labbé Antoine
Phacoemulsification with iStent inject W effectively lowered IOP and medication burden in controlled open-angle glaucoma patients, offering a safe option for concurrent cataract and glaucoma management.
Kolko Miriam, Gazzard Gus, Baudouin Christophe, Beier Sofie, Brignole-Baudouin Françoise, Cvenkel Barbara et al.
Adrian Julien, Authié Colas, Lebrun Johan, Lombardi Marco, Zenouda Ariel, Gutman Emmanuel et al.
This study found glaucoma patients exhibit unsafe driving behaviors and slower reactions in a simulator, despite compensatory strategies. This highlights significant driving safety concerns for individuals with glaucoma.
Bertaud Samuel, Zenouda Ariel, Lombardi Marco, Authié Colas, Brasnu Emmanuelle, Hamard Pascale et al.
This study found moderate to severe glaucoma patients experience significant glare disability, which substantially impairs their mobility performance, highlighting real-world functional challenges.
Augstburger Edouard, Ballino Arnaud, Keilani Chafik, Robin Mathieu, Baudouin Christophe, Labbé Antoine
OCT-A showed significant, progressive reduction in radial peripapillary and superficial capillary density in NAION, correlating with vision and nerve damage. This highlights vascular impact and its clinical relevance.
Souissi Soufiane, Le Mer Yannick, Metge Florence, Portmann Alexandre, Baudouin Christophe, Labbé Antoine et al.
This review found MP-TLT offers better safety than CW-CPC for refractory glaucoma, while ECP is preferred for pediatric cases. More research is needed for broader use.
Baudouin Christophe, Kolko Miriam, Melik-Parsadaniantz Stéphane, Messmer Elisabeth M
This review highlights that inflammation is a widespread, dysregulated process throughout the eye in glaucoma, contributing to disease progression and offering potential anti-inflammatory therapeutic targets.
Azoulay-Sebban Line, Zhao Zhanlin, Zenouda Ariel, Lombardi Marco, Gutman Emmanuel, Brasnu Emmanuelle et al.
Glaucoma patients experience reduced quality of life and impaired daily activities. The worse eye's visual field strongly correlates with QoL, indicating its importance for assessing patient well-being.
Chamard Chloé, Larrieu Sophie, Baudouin Christophe, Bron Alain, Villain Max, Daien Vincent
This study found that glaucoma patients using preserved eye drops had a significantly higher risk of needing glaucoma surgery, suggesting a benefit for preservative-free formulations.
El Chehab Hussam, Gatinel Damien, Baudouin Christophe, Muraine Marc, Hoffart Louis, Rozot Pascal et al.
Cosmetic iris implants caused complications in 92% of 65 eyes, including corneal damage (78%) and glaucoma (52%), often requiring removal and leading to vision loss, highlighting significant risks for patients.
Dubrulle Pierre, Labbé Antoine, Brasnu Emmanuelle, Liang Hong, Hamard Pascale, Meziani Lyes et al.
Treating ocular surface disease in glaucoma patients with uncontrolled IOP significantly improved ocular surface health and lowered IOP, often reducing medication burden and potentially delaying surgery.
Lombardi Marco, Zenouda Ariel, Azoulay-Sebban Line, Lebrisse Marie, Gutman Emmanuel, Brasnu Emmanuelle et al.
This study found binocular visual field tests (IVF, Esterman) and better-eye MD best correlate with glaucoma patients' performance in simulated daily tasks, highlighting their clinical importance for assessing real-world function.
Aragno Vittoria, Labbé Antoine, Brion Frédérique, Baudouin Christophe, Hamard Pascale
NPDS effectively lowers mean IOP and reduces posture-induced IOP fluctuations in OAG, though dependent lateral decubitus position still shows higher IOP, suggesting avoidance for asymmetric cases.
Augstburger Edouard, Zéboulon Pierre, Keilani Chafik, Baudouin Christophe, Labbé Antoine
OCT-A in NAION patients revealed significant peripapillary and macular retinal capillary loss, correlating with vision and visual field deficits. This suggests OCT-A can monitor NAION-related ischemia.
Buffet Jenna, Brasnu Emmanuelle, Baudouin Christophe, Labbé Antoine
This study found two micro-bypass stents during cataract surgery modestly lowered IOP (10-13%) and medication use (23-40%) for 2 years in controlled glaucoma, offering a beneficial adjunct therapy.
Zéboulon Pierre, Lévêque Pierre-Maxime, Brasnu Emmanuelle, Aragno Vittoria, Hamard Pascale, Baudouin Christophe et al.
Surgical IOP lowering in glaucoma showed minimal to no significant change in peripapillary and macular vessel density, suggesting limited direct impact on microvasculature.
Datta Sandipan, Baudouin Christophe, Brignole-Baudouin Francoise, Denoyer Alexandre, Cortopassi Gino A
BAK eye drop preservative potently damages mitochondria in eye cells, especially those with LHON mutations, suggesting it underlies ocular toxicity. Avoid BAK drops in patients with mitochondrial deficiencies.
Aragno Vittoria, Zeboulon Pierre, Baudouin Christophe, Labbé Antoine
This case highlights severe pediatric pigmentary glaucoma linked to familial pigment dispersion syndrome, emphasizing the need for early screening in affected children.
Meziani Lyes, Tahiri Joutei Hassani Rachid, El Sanharawi Mohamed, Brasnu Emmanuelle, Liang Hong, Hamard Pascale et al.
En-face OCT showed functioning glaucoma blebs have more intraepithelial microcysts, correlating with lower eye pressure and less prior preserved eyedrop use, offering a non-invasive bleb assessment.